(19)
(11) EP 3 145 510 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.10.2021 Bulletin 2021/43

(45) Mention of the grant of the patent:
30.06.2021 Bulletin 2021/26

(21) Application number: 15727228.7

(22) Date of filing: 22.05.2015
(51) International Patent Classification (IPC): 
A61N 5/06(2006.01)
A61K 31/498(2006.01)
A61K 31/7048(2006.01)
A61K 31/133(2006.01)
 A61K 31/496(2006.01)
A61K 31/5383(2006.01)
A61K 31/438(2006.01)
A61P 31/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/07; A61K 31/133; A61K 31/435; A61K 31/438; A61K 31/496; A61K 31/498; A61K 31/5383; A61K 31/59; A61K 31/7048; A61N 5/0624; A61N 2005/0661; A61P 1/00; A61P 17/00; A61P 17/06; A61P 21/00; A61P 29/00; A61P 37/00
 
C-Sets:
  1. A61K 31/438, A61K 2300/00;
  2. A61K 31/133, A61K 2300/00;
  3. A61K 31/7048, A61K 2300/00;
  4. A61K 31/498, A61K 2300/00;
  5. A61K 31/496, A61K 2300/00;
  6. A61K 31/5383, A61K 2300/00;
(86) International application number:
PCT/US2015/032255
(87) International publication number:
WO 2015/179809 (26.11.2015 Gazette 2015/47)

(54)

TREATMENT OF DISEASES USING COMBINATION OF ULTRAVIOLET BLOOD IRRADIATION AND ANTIBIOTICS

BEHANDLUNG VON KRANKHEITEN MITTELS KOMBINATION AUS ULTRAVIOLETTER BLUTBESTRAHLUNG UND ANTIBIOTIKA

TRAITEMENT DE MALADIES PAR COMBINAISON D'UNE IRRADIATION SANGUINE PAR ULTRAVIOLET ET D'ANTIBIOTIQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 22.05.2014 US 201462002141 P

(43) Date of publication of application:
29.03.2017 Bulletin 2017/13

(73) Proprietor: Kuenstner, John, Todd
Abington, Pennsylvania 19001 (US)

(72) Inventor:
  • Kuenstner, John, Todd
    Abington, Pennsylvania 19001 (US)

(74) Representative: Murgitroyd & Company 
Murgitroyd House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
WO-A1-98/43667
WO-A1-2013/181694
WO-A2-2013/041963
 WO-A1-2009/097651
WO-A2-2006/096827
RU-C1- 2 142 821
   
  • J TODD KUENSTNER: "Resolution of Crohn's disease and complex regional pain syndrome following treatment of paratuberculosis", WORLD JOURNAL OF GASTROENTEROLOGY, vol. 21, no. 13, 1 January 2015 (2015-01-01), page 4048, XP055203688, ISSN: 1007-9327, DOI: 10.3748/wjg.v21.i13.4048
  • KUENSTNER J TODD ED - HOMMES DANIEL ET AL: "Mycobacterium avium paratuberculosis and Crohn's Disease: An association requiring more research", JOURNAL OF CROHN'S AND COLITIS, ELSEVIER BV, NL, vol. 6, no. 3, 11 January 2012 (2012-01-11), page 393, XP028905389, ISSN: 1873-9946, DOI: 10.1016/J.CROHNS.2011.12.017
  • None
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).